U.S. Healthtech Stock News

EVERTEC (EVTC) is back in focus after issuing 2026 earnings guidance, reporting full year 2025 results, and expanding its share buyback plan. These updates give investors fresh numbers to evaluate the payments company. See our latest analysis for EVERTEC. Despite the new guidance, buyback expansion, and conference appearance, EVERTEC’s recent share price performance has been subdued, with a 30 day share price return of 1.39% and a 1 year total shareholder return decline of 22.90%, suggesting...

Forestar Group (NYSE:FOR) is seeing weaker lot sales alongside negative free cash flow margins over the past two years. These pressures point to rising operational challenges and tighter profitability for the land developer. Investors are weighing these trends against the company’s recent share price performance and current valuation. Forestar Group, trading at $25.96, has had a mixed stretch in the market, with the stock down 9.6% over the past week and 11.6% over the past month. Over a...

GPGI (NYSE:GPGI) has appointed David A.P. Marshall as Chief Legal Counsel and Corporate Secretary. Marshall will hold the same roles at Resolute Holdings, aligning legal leadership across both entities. The appointment brings experience from a prominent law firm into GPGI’s executive ranks. Stakeholders are watching the leadership change for its potential impact on governance and legal priorities. For you as an investor following NYSE:GPGI, a new Chief Legal Counsel and Corporate Secretary...

Oklo (OKLO) is back in focus after confirming a binding agreement with Meta Platforms to co develop a 1.2 gigawatt advanced nuclear campus in Ohio, backed by significant prepayment funding for future power. See our latest analysis for Oklo. Oklo’s recent Meta agreement comes after a sharp pullback, with the 30 day share price return at a 14.63% decline and the 90 day share price return at a 44.35% decline. However, the 1 year total shareholder return is 121.74% and the 3 year total...

If you are wondering whether Axalta Coating Systems is priced attractively right now, this article walks through what the current share price could mean for potential value. The stock last closed at US$29.61, with returns of 11.4% decline over 7 days, 13.6% decline over 30 days, 10.3% decline year to date and 15.2% decline over the past year. These moves may have changed how the market is thinking about its risk and return profile. Recent coverage around Axalta has focused on its position in...

MYR Group (MYRG) is back in focus after reporting fourth quarter and full year 2025 results that showed higher sales and net income versus 2024, highlighting a shift in profitability that investors are reassessing. See our latest analysis for MYR Group. The latest earnings release comes after a strong run, with a 90 day share price return of 14.16% and a one year total shareholder return of 131.56%. This suggests momentum has been building despite a recent pullback to US$260.9 and a 7 day...

In February 2026, Digi International launched a Model Context Protocol (MCP) server for Digi Remote Manager and Genesis, enabling secure integration of large language model assistants like Claude to manage and optimize connected infrastructure and wireless WAN deployments via natural language interfaces. This move deepens the link between AI and edge connectivity, positioning Digi’s management platforms as hubs for secure, context-aware automation across distributed device fleets. We’ll now...

Senior executives at Comfort Systems USA, including the Director and Chief Accounting Officer, have disclosed a series of insider share sales. The transactions were reported shortly after the company announced record financial results and major expansion plans to increase modular system capacity. The timing of these insider moves comes as Comfort Systems USA (NYSE: FIX) highlights robust demand tied to data center related projects and strong project backlogs. Comfort Systems USA (NYSE: FIX)...

Event driven context for Lyft stock Lyft (LYFT) has recently drawn attention after a period of mixed share performance, with returns over the past month, past 3 months and year to date highlighting how sentiment around the rideshare platform has shifted. See our latest analysis for Lyft. At a share price of US$13.25, Lyft’s recent 30 day share price return of an 18.01% decline and 90 day share price return of a 42.32% decline contrast with a 1 year total shareholder return of 6.77%,...

Campbell's (CPB) has come under pressure, with shares recently sliding 3.7% as analysts turned more cautious ahead of the upcoming fiscal 2026 second quarter earnings report, citing concerns related to margins, volumes, leverage, and credit. See our latest analysis for Campbell's. At a latest share price of $25.8, Campbell's has seen a 10.14% 30 day share price decline and a 35.16% 1 year total shareholder return decline, suggesting momentum has been fading as concerns around margins,...

Orion Properties (ONL) just posted its FY 2025 numbers with Q4 total revenue of US$36.0 million and a basic EPS loss of US$0.64, while trailing twelve month revenue came in at US$147.6 million alongside a basic EPS loss of US$2.48. Over recent quarters, the company has seen revenue move from US$38.1 million in Q4 FY 2024 to US$37.8 million, US$37.0 million, US$36.9 million and then US$36.0 million, with quarterly basic EPS losses ranging from US$0.17 to US$1.23 before landing at US$0.64 in...

Ascendis Pharma A/S recently received FDA accelerated approval for YUVIWEL (navepegritide; TransCon CNP), the first once-weekly treatment to increase linear growth in children aged two and older with achondroplasia and open epiphyses, supported by data from three randomized, double-blind, placebo-controlled trials and up to three years of extension studies. The approval also granted Ascendis a Rare Pediatric Disease Priority Review Voucher and will be backed by the Ascendis Signature Access...

In late February 2026, Paycom Software reported Q4 results with a 10.2% year-on-year revenue increase but issued cautious full-year guidance pointing to slower growth and softer HR software demand. Management highlighted ongoing investment in AI tools like Beti and IWant, alongside plans for international expansion and a new dividend, underscoring a shift toward efficiency, retention and broader market reach. We’ll now examine how Paycom’s cautious full-year outlook, despite AI-driven...

If you are wondering whether Alphabet's share price still makes sense after a long run, this article will walk through how the current market price lines up with different ways of thinking about value. Alphabet recently closed at US$298.52, with returns of a 4.2% decline over 7 days, a 9.9% decline over 30 days and a 5.3% decline year to date. The 1-year return stands at 72.4% and the 3-year and 5-year returns are 231.9% and 193.4% respectively. Recent attention on Alphabet has been shaped...

Synchrony Financial (NYSE:SYF) has renewed its long-term financing partnership with Polaris, a major powersports manufacturer. The company is also expanding its retail financing reach through a new partnership with Walmart. Both agreements are expected to widen access to Synchrony’s credit solutions and use of its PRISM decisioning technology. For investors watching NYSE:SYF at a share price of $66.67, these partnerships sit against a mixed recent return profile. The stock shows a 24.0%...

Intuit (NasdaqGS:INTU) has partnered with Anthropic to offer custom AI agents tailored for mid market businesses. The companies are integrating Intuit’s tax, accounting, and financial management tools directly into Anthropic’s AI suite. The collaboration aims to support new workflow and automation capabilities for both business and consumer users. For you as an investor, this move ties Intuit’s core products in tax filing, bookkeeping, and personal finance more tightly to a fast growing...

Clinical milestones and earnings set the context for Compass Therapeutics stock Compass Therapeutics (CMPX) has been in focus after reaching the planned survival event threshold in its Phase 2/3 COMPANION-002 trial for biliary tract cancer, along with FDA clearance for its CTX-10726 investigational program. These developments come as the company reported a full year 2025 net loss of US$66.49 million and a fourth quarter net loss of US$15.72 million, figures that help frame current...

J. M. Smucker (NYSE:SJM) announced significant leadership changes, including the departure of former President and COO John Brase. The company also appointed Woo-Sung (Bruce) Chung and David Singer to its Board of Directors as new independent members. These moves reshape the governance and decision-making framework at J. M. Smucker and may be closely watched by investors. Shares of J. M. Smucker recently closed at $111.21, with a year-to-date return of 15.1% and a 5-year return of 8.3%...

AAR CORP. recently announced a new agreement with Otto Instrument Service to sell and support the LASEREF IV inertial reference system, enhancing availability and deployment of this key avionics unit for business aircraft replacements and upgrades. This collaboration combines Otto’s technical expertise with AAR’s global supply-chain reach and distribution infrastructure, deepening AAR’s presence in the business aviation aftermarket. We’ll now examine how this new LASEREF IV distribution...

If you are wondering whether Humana's current share price reflects its underlying worth, you are not alone. This article is built to help you connect the stock price to what the business may be worth. Humana's share price closed at US$179.15, with returns of 6.0% decline over 7 days, 6.7% decline over 30 days, a 32.3% decline year to date, and a 30.1% decline over 1 year, while the 3 year and 5 year returns are 61.4% decline and 53.9% decline respectively. Recent coverage of Humana has...

If you are wondering whether General Dynamics at around US$363.49 is still offering value after a strong run, you are not alone. This article unpacks what the current price might imply. The stock has logged returns of 1.8% over the last 7 days, 2.9% over 30 days, 5.9% year to date, 36.4% over 1 year, 75.1% over 3 years and 129.9% over 5 years. These figures raise fair questions about how much of the story is already in the price. Recent news coverage has focused on General Dynamics' role as...

Why Mattel Is On Investors’ Radar Now Mattel (MAT) has seen its share price under pressure recently, with returns over the past month and past 3 months both negative. That kind of pullback often prompts investors to reassess what they are paying for the business. See our latest analysis for Mattel. At a share price of $15.90, Mattel’s recent 7 day share price return of 6.19% decline and 30 day share price return of 25.32% decline sit alongside a 1 year total shareholder return of 24.29%...

Eve Holding (EVEX) is back in the spotlight after VERTICON 2026, where Eve Air Mobility highlighted progress in its eVTOL flight testing, deeper operator partnerships, and two new binding agreements covering up to 100 aircraft. See our latest analysis for Eve Holding. Despite the news flow around VERTICON 2026 and upcoming Q4 2025 results on 6 March, Eve Holding’s share price has retreated. The 30 day share price return is 20% and the 90 day share price return is 39.8%. This has contributed...

Exact Sciences (NasdaqCM:EXAS), Amalgam Rx, and Privia Health rolled out a nationwide, EHR-enabled outreach program focused on colorectal cancer screening. The program uses Exact Sciences' Cologuard test integrated into electronic health records to reach and engage at-risk patients at scale. According to the case study, participating groups recorded colorectal cancer screening rates that outperformed national benchmarks and goals. The initiative also reports lower staff workload by...